Literature DB >> 18474353

CO-opting the host HO-1 pathway in tuberculosis and malaria.

Photini Sinnis1, Joel D Ernst.   

Abstract

Infection with Mycobacterium tuberculosis and Plasmodium species results in upregulation of the host heme oxygenase-1 pathway. In tuberculosis infection, this leads to upregulation of the bacterial "dormancy regulon," whereas in malaria, it enhances the efficiency with which sporozoites develop into exoerythrocytic stages. Here we discuss these findings as well as some of the interesting questions they raise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474353     DOI: 10.1016/j.chom.2008.04.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  5 in total

Review 1.  The emerging role of gasotransmitters in the pathogenesis of tuberculosis.

Authors:  Krishna C Chinta; Vikram Saini; Joel N Glasgow; James H Mazorodze; Md Aejazur Rahman; Darshan Reddy; Jack R Lancaster; Adrie J C Steyn
Journal:  Nitric Oxide       Date:  2016-07-04       Impact factor: 4.427

2.  Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice.

Authors:  Nathan W Cummins; Eric A Weaver; Shannon M May; Anthony J Croatt; Oded Foreman; Richard B Kennedy; Gregory A Poland; Michael A Barry; Karl A Nath; Andrew D Badley
Journal:  FASEB J       Date:  2012-04-06       Impact factor: 5.191

Review 3.  Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases.

Authors:  Matthew Bates; Ben J Marais; Alimuddin Zumla
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

4.  Structural insight into the heme-based redox sensing by DosS from Mycobacterium tuberculosis.

Authors:  Ha Yeon Cho; Hyo Je Cho; Young Min Kim; Jeong Il Oh; Beom Sik Kang
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

Review 5.  Expanding the antimalarial toolkit: Targeting host-parasite interactions.

Authors:  Jean Langhorne; Patrick E Duffy
Journal:  J Exp Med       Date:  2016-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.